Granite Point Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-43,133
Closed -$616K 105
2016
Q2
$616K Buy
+43,133
New +$659K 0.26% 62
2015
Q4
$890K Hold
51,583
0.13% 45
2015
Q3
$629K Hold
51,583
0.43% 53
2015
Q2
$622K Sell
51,583
-24,317
-32% -$239K 0.18% 65
2015
Q1
$636K Hold
75,900
0.23% 67
2014
Q4
$581K Hold
75,900
0.27% 60
2014
Q3
$522K Hold
75,900
0.26% 62
2014
Q2
$628K Sell
75,900
-10,205
-12% -$79.8K 0.43% 54
2014
Q1
$695K Sell
86,105
-5,900
-6% -$47.2K 0.5% 64
2013
Q4
$737K Buy
+92,005
New +$712K 0.12% 76

Other funds holding LMAT

Granite Point Capital Management's LMAT Position: Q3 2016 in Review

Granite Point Capital Management sold out of LeMaitre Vascular (LMAT) in Q3 2016, closing a stake of 43,133 shares — an estimated $616K sold.

Granite Point Capital Management first reported a position in LMAT in Q4 2013 and held it in 10 quarters. The position peaked at $890K in Q4 2015. 111 funds tracked by Wall St. Rank hold LMAT as of Q3 2016.

  • Granite Point Capital Management reported no remaining LeMaitre Vascular position as of Q3 2016 after selling out during the quarter.
  • Granite Point Capital Management sold 43,133 LeMaitre Vascular shares in Q3 2016, an estimated $616K.
  • Granite Point Capital Management first reported a position in LeMaitre Vascular in Q4 2013 and held it in 10 quarters.
  • Granite Point Capital Management's LeMaitre Vascular position peaked at $890K in Q4 2015.
  • 111 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2016.

Based on Granite Point Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.